Impact of SGLT2 inhibitors on liver-related outcomes in patients with heart failure - a population-based study in HK

被引：0
|
作者：
Yang, H. Y. [1 ]
Yang, R. Q. [2 ]
Yiu, K. H. [1 ]
机构：
[1] Queen Mary Hosp, Hong Kong, Peoples R China
[2] Nanchang Univ, Dept Med, Cardiol Div, Affiliated Hosp 2, Nanchang, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of SGLT2 inhibitors on liver-related outcomes in patients with heart failure - a population-based study in HK
    Yang, H. Y.
    Yang, R. Q.
    Yiu, K. H.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [2] The Impact of the Withdrawal of SGLT2 Inhibitors on Clinical Outcomes in Patients with Heart Failure
    Nakagaito, Masaki
    Imamura, Teruhiko
    Ushijima, Ryuichi
    Nakamura, Makiko
    Kinugawa, Koichiro
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [3] SGLT2 Inhibitors and Heart Failure Outcomes
    Chim, Christine
    Newaz, Shahreear
    US PHARMACIST, 2020, 45 (02) : 18 - 22
  • [4] SGLT2 inhibitors in frail patients with Heart Failure - tolerability & outcomes
    Mannion, T. Tara
    O'connor, L.
    O'gara, G.
    Kelly-O'haire, J.
    Cooney, H.
    Mcadam, B.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 266 - 266
  • [5] The Impact of SGLT2 Inhibitors on Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
    Starr, Jessica A.
    Pinner, Nathan A.
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (05) : 506 - 513
  • [6] Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction
    Starr, Jessica A.
    Pinner, Nathan A.
    Lisenby, Katelin M.
    Osmonson, Alyssa
    PHARMACOTHERAPY, 2021, 41 (06): : 526 - 536
  • [7] Pleiotropic effects of SGLT2 inhibitors and heart failure outcomes
    Theofilis, Panagiotis
    Sagris, Marios
    Oikonomou, Evangelos
    Antonopoulos, Alexios S.
    Siasos, Gerasimos
    Tsioufis, Kostas
    Tousoulis, Dimitris
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 188
  • [8] Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction.
    Mariana Tinoco, M.
    Cardoso, F.
    Dias, G.
    Pereira, T.
    Faria, B.
    Almeida, F.
    Leite, S.
    Lourenco, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 112 - 112
  • [9] Efficacy of Continuing SGLT2 Inhibitors on Outcomes in Patients with Acute Decompensated Heart Failure
    Nakagaito, Masaki
    Imamura, Teruhiko
    Joho, Shuji
    Ushijima, Ryuichi
    Nakamura, Makiko
    Kinugawa, Koichiro
    INTERNATIONAL HEART JOURNAL, 2021, 62 (04) : 885 - 890
  • [10] SGLT2 Inhibitors and Their Effect on Metabolism in Patients With Heart Failure
    Wiggers, Henrik
    CIRCULATION-HEART FAILURE, 2024, 17 (11)
12345